Skip to main content
Top
Published in:

Open Access 01-12-2017 | Research

Observation of the influences of diosgenin on aging ovarian reserve and function in a mouse model

Authors: Mingjie Shen, Cong Qi, Yan-Ping Kuang, Yang Yang, Qi-Feng Lyu, Hui Long, Zhi-Guang Yan, Ying-Yu Lu

Published in: European Journal of Medical Research | Issue 1/2017

Login to get access

Abstract

Background

The aim of this study was to investigate the impact of diosgenin, an important monomer of sapogenins in yams, on ovarian reserve in a natural aging mice model.

Study design

This randomized controlled trial included 60 9-month-old C57 naturally aging female mice. Twenty-one mice were assigned to the dio group and were fed a single dose of diosgenin (200 mg/kg/day) suspended in 0.3% CMC. Twenty mice were assigned to the DHEA group and were fed a single dose of DHEA (1.25 mg/kg/day) suspended in 0.3% CMC. The remaining 20 mice were assigned to the old control group and were fed a single dose of 0.3% CMC. Three months later, the reproductive performance of these female mice was determined by evaluating ovarian follicles and oocyte number and quality in IVF and comparing age-matched and young controls. The impact of NOBOX, GDF9 and BMP15 mRNA expression was also evaluated.

Results

Diosgenin improves ovarian reserve in naturally aging mice in terms of increasing the number of primary follicles (P < 0.05) and serum levels of AMH (P < 0.05).

Conclusions

Diosgenin could counteract age-associated ovarian dysfunction by improving the ovarian reserve in a natural aging mice model.
Literature
1.
2.
go back to reference Broer SL, Disseldorp JV, Broeze KA, et al. Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach. Hum Reprod Update. 2013;19:26–36.CrossRefPubMed Broer SL, Disseldorp JV, Broeze KA, et al. Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach. Hum Reprod Update. 2013;19:26–36.CrossRefPubMed
4.
go back to reference Johnson J, Canning J, Kaneko T, Pru JK, Tilly JL. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature. 2004;428:145–50.CrossRefPubMed Johnson J, Canning J, Kaneko T, Pru JK, Tilly JL. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature. 2004;428:145–50.CrossRefPubMed
5.
go back to reference Johnson J, Bagley J, Skaznik-Wikiel M, et al. Oocyte generation in adult mammalian ovaries by putative germ cells in bone marrow and peripheral blood. Cell. 2005;122:303–15.CrossRefPubMed Johnson J, Bagley J, Skaznik-Wikiel M, et al. Oocyte generation in adult mammalian ovaries by putative germ cells in bone marrow and peripheral blood. Cell. 2005;122:303–15.CrossRefPubMed
6.
go back to reference McGee EA, Hsueh AJ. Initial and cyclic recruitment of ovarian follicles. Endocr Rev. 2000;21:200–14.PubMed McGee EA, Hsueh AJ. Initial and cyclic recruitment of ovarian follicles. Endocr Rev. 2000;21:200–14.PubMed
7.
go back to reference Wallace WH, Kelsey TW. Human ovarian reserve from conception to the menopause. PLoS ONE. 2010;5:1–7. Wallace WH, Kelsey TW. Human ovarian reserve from conception to the menopause. PLoS ONE. 2010;5:1–7.
8.
go back to reference Broekmans FJ, Soules MR, Fauser BC. Ovarian aging: mechanisms and clinical consequences. Endocr Rev. 2009;30:465–93.CrossRefPubMed Broekmans FJ, Soules MR, Fauser BC. Ovarian aging: mechanisms and clinical consequences. Endocr Rev. 2009;30:465–93.CrossRefPubMed
10.
go back to reference Reddy P, Shen L, Ren C, Boman K, Lundin E, Ottander U, Lindgren P, Liu YX, Sun QY, Liu K. Activation of Akt (PKB) and suppression of FKHRL1 in mouse and rat oocytes by stem cell factor during follicular activation and development. Dev Biol. 2005;281:160–70.CrossRefPubMed Reddy P, Shen L, Ren C, Boman K, Lundin E, Ottander U, Lindgren P, Liu YX, Sun QY, Liu K. Activation of Akt (PKB) and suppression of FKHRL1 in mouse and rat oocytes by stem cell factor during follicular activation and development. Dev Biol. 2005;281:160–70.CrossRefPubMed
12.
go back to reference Rajkovic A, Pangas SA, Ballow D, et al. NOBOX deficiency disrupts early folliculogenesis and oocyte-specific gene expression. Science. 2004;305:1157–9.CrossRefPubMed Rajkovic A, Pangas SA, Ballow D, et al. NOBOX deficiency disrupts early folliculogenesis and oocyte-specific gene expression. Science. 2004;305:1157–9.CrossRefPubMed
13.
go back to reference Sautour M, Mitaine-Offer AC, Miyamoto T, et al. Antifungal steroid saponins from Dioscorea cayenensis. Planta Med. 2004;70:90–2.CrossRefPubMed Sautour M, Mitaine-Offer AC, Miyamoto T, et al. Antifungal steroid saponins from Dioscorea cayenensis. Planta Med. 2004;70:90–2.CrossRefPubMed
14.
go back to reference Scott A, Higdon K, Tucci M, et al. The prevention of osteoporotic progression by means of steroid loaded TCPL drug delivery systems. Biomed Sci Instrum. 2001;37:13–8.PubMed Scott A, Higdon K, Tucci M, et al. The prevention of osteoporotic progression by means of steroid loaded TCPL drug delivery systems. Biomed Sci Instrum. 2001;37:13–8.PubMed
15.
go back to reference Liagre B, Vergne-Salle P, Corbiere C, et al. Diosgenin, a plant steroid, induces apoptosis in human rheumatoid arthritis synoviocytes with cyclooxygenase-2 overexpression. Arthritis Res Ther. 2004;6:373–83.CrossRef Liagre B, Vergne-Salle P, Corbiere C, et al. Diosgenin, a plant steroid, induces apoptosis in human rheumatoid arthritis synoviocytes with cyclooxygenase-2 overexpression. Arthritis Res Ther. 2004;6:373–83.CrossRef
16.
go back to reference Raju J, Mehta R. Cancer chemopreventive and therapeutic effects of diosgenin, a food saponin. Nutr Cancer. 2009;61:27–35.CrossRefPubMed Raju J, Mehta R. Cancer chemopreventive and therapeutic effects of diosgenin, a food saponin. Nutr Cancer. 2009;61:27–35.CrossRefPubMed
17.
go back to reference Lepage C, Léger DY, Bertrand J, et al. Diosgenin induces death receptor-5 through activation of p38 pathway and promotes TRAIL-induced apoptosis in colon cancer cells. Cancer Lett. 2011;301:193–202.CrossRefPubMed Lepage C, Léger DY, Bertrand J, et al. Diosgenin induces death receptor-5 through activation of p38 pathway and promotes TRAIL-induced apoptosis in colon cancer cells. Cancer Lett. 2011;301:193–202.CrossRefPubMed
18.
go back to reference Chen PS, Shih YH, Huang HC, et al. Diosgenin, a steroidal saponin, inhibits migration and invasion of human prostate cancer PC-3 cells by reducing matrix metalloproteinases expression. PLoS ONE. 2011;6:e20164.CrossRefPubMedPubMedCentral Chen PS, Shih YH, Huang HC, et al. Diosgenin, a steroidal saponin, inhibits migration and invasion of human prostate cancer PC-3 cells by reducing matrix metalloproteinases expression. PLoS ONE. 2011;6:e20164.CrossRefPubMedPubMedCentral
19.
go back to reference Wang YJ, Pan KL, Hsieh TC, et al. Diosgenin, a plant derived sapogenin, exhibits antiviral activity in vitro against hepatitis C virus. J Nat Prod. 2011;74:580–4.CrossRefPubMed Wang YJ, Pan KL, Hsieh TC, et al. Diosgenin, a plant derived sapogenin, exhibits antiviral activity in vitro against hepatitis C virus. J Nat Prod. 2011;74:580–4.CrossRefPubMed
20.
go back to reference Jung DH, Park HJ, Byun HE, et al. Diosgenin inhibits macrophage-derived inflammatory mediators through downregulation of CK2, JNK, NF-κB and AP-1 activation. Int Immunopharmacol. 2010;10:1047–54.CrossRefPubMed Jung DH, Park HJ, Byun HE, et al. Diosgenin inhibits macrophage-derived inflammatory mediators through downregulation of CK2, JNK, NF-κB and AP-1 activation. Int Immunopharmacol. 2010;10:1047–54.CrossRefPubMed
21.
go back to reference Liu K, Zhao W, Gao X, et al. Diosgenin ameliorates palmitate-induced endothelial dysfunction and insulin resistance via blocking IKKβ and IRS-1 pathways. Atherosclerosis. 2012;223:350–8.CrossRefPubMed Liu K, Zhao W, Gao X, et al. Diosgenin ameliorates palmitate-induced endothelial dysfunction and insulin resistance via blocking IKKβ and IRS-1 pathways. Atherosclerosis. 2012;223:350–8.CrossRefPubMed
22.
go back to reference Myers M, Britt KL, Wreford NG, et al. Methods for quantifying follicular numbers within the mouse ovary. Reproduction. 2004;127:569–80.CrossRefPubMed Myers M, Britt KL, Wreford NG, et al. Methods for quantifying follicular numbers within the mouse ovary. Reproduction. 2004;127:569–80.CrossRefPubMed
23.
go back to reference Faddy MJ, Gosden RG, Gougeon A, et al. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod. 1992;7:1342–6.CrossRefPubMed Faddy MJ, Gosden RG, Gougeon A, et al. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod. 1992;7:1342–6.CrossRefPubMed
24.
go back to reference Jeppesen JV, Anderson RA, Kelsey TW, et al. Which follicles make the most anti-Mullerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection. Mol Hum Reprod. 2013;19:519–27.CrossRefPubMed Jeppesen JV, Anderson RA, Kelsey TW, et al. Which follicles make the most anti-Mullerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection. Mol Hum Reprod. 2013;19:519–27.CrossRefPubMed
25.
go back to reference Visser JA, de Jong FH, Laven JS, et al. Anti-Mullerian hormone: a new marker for ovarian function. Reproduction. 2006;131:1–9.CrossRefPubMed Visser JA, de Jong FH, Laven JS, et al. Anti-Mullerian hormone: a new marker for ovarian function. Reproduction. 2006;131:1–9.CrossRefPubMed
26.
go back to reference Dong J, Albertini DF, Nishimori K, et al. Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature. 1996;383:531–5.CrossRefPubMed Dong J, Albertini DF, Nishimori K, et al. Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature. 1996;383:531–5.CrossRefPubMed
27.
go back to reference Yan C, Wang P, DeMayo J, et al. Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function. Mol Endocrinol. 2001;15:854–66.CrossRefPubMed Yan C, Wang P, DeMayo J, et al. Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function. Mol Endocrinol. 2001;15:854–66.CrossRefPubMed
28.
go back to reference Choi Y, Rajkovic A. Genetics of early mammalian folliculogenesis. Cell Mol Life Sci. 2006;63:579–90.CrossRefPubMed Choi Y, Rajkovic A. Genetics of early mammalian folliculogenesis. Cell Mol Life Sci. 2006;63:579–90.CrossRefPubMed
29.
go back to reference Choi Y, Rajkovic A. Characterization of NOBOX DNA binding specificity and its regulation of Gdf9 and Pou5f1 promoters. J Biol Chem. 2006;281:35747–56.CrossRefPubMed Choi Y, Rajkovic A. Characterization of NOBOX DNA binding specificity and its regulation of Gdf9 and Pou5f1 promoters. J Biol Chem. 2006;281:35747–56.CrossRefPubMed
30.
go back to reference Choi Y, Qin Y, Berger MF, et al. A microarray analyses of newborn mouse ovaries lacking NOBOX. Biol Reprod. 2007;77:312–9.CrossRefPubMed Choi Y, Qin Y, Berger MF, et al. A microarray analyses of newborn mouse ovaries lacking NOBOX. Biol Reprod. 2007;77:312–9.CrossRefPubMed
31.
go back to reference Huntriss J, Hinkins M, Picton HM. cDNA cloning and expression of the human NOBOX gene in oocytes and ovarian follicles. Mol Hum Reprod. 2006;12:283–9.CrossRefPubMed Huntriss J, Hinkins M, Picton HM. cDNA cloning and expression of the human NOBOX gene in oocytes and ovarian follicles. Mol Hum Reprod. 2006;12:283–9.CrossRefPubMed
33.
go back to reference Qin Y, Shi Y, Zhao Y, et al. Mutation analysis of NOBOX homeodomain in Chinese women with premature ovarian failure. Fertil Steril. 2009;91:1507–9.CrossRefPubMed Qin Y, Shi Y, Zhao Y, et al. Mutation analysis of NOBOX homeodomain in Chinese women with premature ovarian failure. Fertil Steril. 2009;91:1507–9.CrossRefPubMed
34.
go back to reference Simpson JL. Genetic and phenotypic heterogeneity in ovarian failure: overview of selected candidate genes. Ann NY Acad Sci. 2008;1135:146–54.CrossRefPubMed Simpson JL. Genetic and phenotypic heterogeneity in ovarian failure: overview of selected candidate genes. Ann NY Acad Sci. 2008;1135:146–54.CrossRefPubMed
35.
go back to reference Suzumori N, Yan C, Matzuk MM, et al. NOBOX is a homeobox-encoding gene preferentially expressed in primordial and growing oocytes. Mech Dev. 2002;111:137–41.CrossRefPubMed Suzumori N, Yan C, Matzuk MM, et al. NOBOX is a homeobox-encoding gene preferentially expressed in primordial and growing oocytes. Mech Dev. 2002;111:137–41.CrossRefPubMed
36.
go back to reference Suzumori N, Pangas SA, Rajkovic A. Candidate genes for premature ovarian failure. Curr Med Chem. 2007;14:353–7.CrossRefPubMed Suzumori N, Pangas SA, Rajkovic A. Candidate genes for premature ovarian failure. Curr Med Chem. 2007;14:353–7.CrossRefPubMed
Metadata
Title
Observation of the influences of diosgenin on aging ovarian reserve and function in a mouse model
Authors
Mingjie Shen
Cong Qi
Yan-Ping Kuang
Yang Yang
Qi-Feng Lyu
Hui Long
Zhi-Guang Yan
Ying-Yu Lu
Publication date
01-12-2017
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 1/2017
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-017-0285-6